Most Active Stories
- Groups call growing oil shipments in NY Cuomo's "Keystone" moment
- National Grid says supply costs, cold temperatures impacted winter electric rate spikes
- Death is hard, but hospice can help patients and families
- Nuclear waste facility in political and environmental limbo
- App turns social media posts into charity dollars
Glaxo To Stop Paying Doctors To Promote Drugs
Originally published on Wed December 18, 2013 12:30 am
LINDA WERTHEIMER, HOST:
NPR's business news starts with new rules for Glaxo.
(SOUNDBITE OF MUSIC)
WERTHEIMER: The head of British - the British drug maker GlaxoSmithKline, told The New York Times yesterday that the company will stop paying doctors to promote its drugs. Pharmaceutical firms commonly pay physicians to speak at medical conferences - a practice criticized as a conflict of interest.
Glaxo's CEO told the company - told the paper - the company would also stop paying all its sales reps based on how many prescriptions doctors write. Transcript provided by NPR, Copyright NPR.